APA (7th ed.) Citation

RM, O., L, B., WC, B., K, B., CC, C., C, D., . . . L, Z. (2011). Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. Journal of medicinal chemistry, 54(14), 5082. https://doi.org/10.1021/jm200319u

Chicago Style (17th ed.) Citation

RM, Oballa, et al. "Development of a Liver-targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia." Journal of Medicinal Chemistry 54, no. 14 (2011): 5082. https://doi.org/10.1021/jm200319u.

MLA (9th ed.) Citation

RM, Oballa, et al. "Development of a Liver-targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia." Journal of Medicinal Chemistry, vol. 54, no. 14, 2011, p. 5082, https://doi.org/10.1021/jm200319u.